Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev next > | last >>
presentations: 1 to 50 of 3196
page: of 64 records per page:
SESSION DEDICATION AND OVERVIEW : SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES   (ABSTRACT 1)
John W Mellors
University of Pittsburgh, Pittsburgh, PA, USA
Nicolas Chomont
Université de Montréal, Montreal, Quebec, Canada
Serena S Spudich
Yale University, New Haven, CT, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-COV-2
Theodora Hatziioannou
The Rockefeller University, New York, NY, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
ADVANCES IN HIV AND SARS-COV-2 IMMUNOLOGY
Penny Moore
University of the Witwatersrand, Johannesburg, South Africa
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
ADVANCES IN COVID-19 TREATMENT STRATEGIES AND CONTROLLING THE EPIDEMIC
Carlos del Rio
Emory University, Atlanta, GA, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
ADVANCES IN BIOMEDICAL PREVENTION OF HIV
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
ADVANCES IN HIV CURE WITH CLINICAL PERSPECTIVES
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
LIVE QUESTIONS AND ANSWERS
Nicolas Chomont
Université de Montréal, Montreal, Quebec, Canada
Serena S Spudich
Yale University, New Haven, CT, USA
from CROI 2022 on February 12, 2022 8:30 AM-12:30 PM
CHAIR'S WELCOME TO CROI 2022
Elaine J Abrams
Columbia University, New York, NY, USA
from CROI 2022 on February 13, 2022 8:30 AM-10:45 AM
MARTIN DELANEY PRESENTATION: WE'RE STILL HERE: HIV, AGING, AND THE INVISIBLE GENERATION   (ABSTRACT 2)
Ntando D Yola
University of Cape Town, Cape Town, Western Cape, South Africa
Dawn Averitt
The Well Project, South Strafford, VT, USA
Marc Thompson
PrEPster, London, United Kingdom
James Pickett
AIDS Foundation of Chicago, Chicago, IL, USA
Ntando D Yola
University of Cape Town, Cape Town, Western Cape, South Africa
from CROI 2022 on February 13, 2022 8:30 AM-10:45 AM
BERNARD FIELDS LECTURE: VACCINE STRATEGIES FOR HIV-1 AND COVID-19   (ABSTRACT 3)
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
Dan Barouch
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2022 on February 13, 2022 8:30 AM-10:45 AM
N'GALY-MANN LECTURE: HIV PREVENTION IN VULNERABLE POPULATIONS: GENERATING EVIDENCE TO REDUCE INEQUALITIES   (ABSTRACT 4)
Landon Myer
University of Cape Town, Cape Town, South Africa
Beatriz Grinsztejn
Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
from CROI 2022 on February 13, 2022 8:30 AM-10:45 AM
SPECIAL PRESENTATION: THE COVID-19 EPIDEMIC IN THE UNITED STATES: A DISCUSSION WITH DR ROCHELLE WALENSKY
Elaine J Abrams
Columbia University, New York, NY, USA
Rochelle P Walensky
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 13, 2022 8:30 AM-10:45 AM
SESSION OVERVIEW
Marina B Klein
McGill University Health Centre, Montreal, QC, Canada
SESSION OVERVIEW
David Wyles
Denver Health Medical Center, Denver, CO, USA
LIVER STEATOSIS IN PERSONS LIVING WITH HIV
Maud Lemoine
Imperial College London, London, United Kingdom
QUESTIONS AND ANSWERS WITH THE AUDIENCE (PART I)
Marina B Klein
McGill University Health Centre, Montreal, QC, Canada
QUESTIONS AND ANSWERS WITH THE AUDIENCE (PART I)
David Wyles
Denver Health Medical Center, Denver, CO, USA
GETTING HEPATITIS C AGAIN
Maria Prins
Public Health Service of Amsterdam, Amsterdam, Netherlands
CONTROVERSIES IN HEPATITIS B
Chloe L Thio
Johns Hopkins University, Baltimore, MD, USA
THE ORIGINAL DELTA VIRUS OR D LIKE THE DEVIL
Markus Cornberg
Medizinische Hochschule Hannover, Hannover, Germany
QUESTIONS AND ANSWERS WITH THE AUDIENCE (PART II)
Marina B Klein
McGill University Health Centre, Montreal, QC, Canada
QUESTIONS AND ANSWERS WITH THE AUDIENCE (PART II)
David Wyles
Denver Health Medical Center, Denver, CO, USA
from CROI 2022 on February 13, 2022 11:00 AM-1:00 PM
SESSION OVERVIEW
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
SESSION OVERVIEW
Richard E Chaisson
The Johns Hopkins University, Baltimore, MD, USA
STUDYING COVID TREATMENT OUTCOMES: WHY DISPARATE RESULTS?
Eric J Rubin
New England Journal of Medicine, Boston, MA, USA
ANALYSIS APPROACHES TO CORRELATES OF VACCINE EFFICACY
Peter Gilbert
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
ASSESSING VACCINE EFFICACY IN THE REAL WORLD
Sheena G Sullivan
University of Melbourne, Melbourne, Victoria, Australia
DISCUSSION AND SESSION WRAP-UP
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
DISCUSSION AND SESSION WRAP-UP
Richard E Chaisson
The Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 13, 2022 11:00 AM-1:00 PM
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
SESSION OVERVIEW
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
POPULATION LEVEL VIRAL SEQUENCING
Tulio De Oliveira
Stellenbosch University, Stellenbosch, South Africa
DEEP MUTATIONAL SCANNING TO INTERPRET VIRAL EVOLUTION
Jesse Bloom
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
AI-INSPIRED MONOCLONAL THERAPEUTIC ANTIBODY DESIGN
Regina Barzilay
Massachusetts Institute of Technology, Cambridge, MA, USA
SINGLE-CELL PROTEOMICS
Nikolai Slavov
Northeastern University, Boston, MA, USA
from CROI 2022 on February 13, 2022 11:00 AM-1:00 PM
WELCOME AND DAILY ROADMAP
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
from CROI 2022 on February 14, 2022 8:30 AM-9:30 AM
HIV NONHUMAN PRIMATE MODELS FOR STUDIES OF VIRUS PATHOGENESIS, PERSISTENCE, AND CURE   (ABSTRACT 16)
Michaela Müller-Trutwin
Institut Pasteur, Paris, France
from CROI 2022 on February 14, 2022 8:30 AM-9:30 AM
CHILDREN EXPOSED TO HIV, BUT UNINFECTED: EVIDENCE FOR ACTION   (ABSTRACT 17)
Andrew J Prendergast
Queen Mary University of London, London, United Kingdom
from CROI 2022 on February 14, 2022 8:30 AM-9:30 AM
INTRODUCTION OF SPEAKERS PART I
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
ESTIMATING THE LIFETIME RISK OF A DIAGNOSIS OF HIV INFECTION IN THE UNITED STATES   (ABSTRACT 43)
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LARGE HIV CLUSTERS AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES   (ABSTRACT 44)
Stephen Perez
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
HIV-1 DIAGNOSES IN NORTH CAROLINA, 2018-21: INCIDENT INFECTIONS AND DRUG RESISTANCE   (ABSTRACT 45)
Shuntai Zhou
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
SARS-COV-2 PREVALENCE IN CHILDREN AND ADULTS IN 15 US COMMUNITIES: THE COMPASS STUDY   (ABSTRACT 46)
Jessica E Justman
Columbia University, New York, NY, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Jessica E Justman
Columbia University, New York, NY, USA
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
Stephen Perez
Centers for Disease Control and Prevention, Atlanta, GA, USA
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
Shuntai Zhou
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INTRODUCTION OF SPEAKERS PART II
James A McIntyre
Anova Health Institute, Johannesburg, Gauteng, South Africa
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
SAFETY AND EFFECTIVENESS OF THE AD26.COV2.S VACCINE IN SOUTH AFRICA   (ABSTRACT 47)
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
COVID-19 BOOSTER VACCINE EFFECTIVENESS IN PEOPLE WITH AND WITHOUT IMMUNE DYSFUNCTION   (ABSTRACT 48)
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INFECTIOUSNESS OF BREAKTHROUGH INFECTIONS AFTER VACCINATION AND NATURAL INFECTION   (ABSTRACT 49)
Laith J Abu-Raddad
Weill Cornell Medicine-Qatar, Doha, Qatar
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
COVID-19 VACCINATION RATES IN A GLOBAL HIV COHORT   (ABSTRACT 50)
Evelynne S Fulda
Massachusetts General Hospital, Boston, MA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Laith J Abu-Raddad
Weill Cornell Medicine-Qatar, Doha, Qatar
James A McIntyre
Anova Health Institute, Johannesburg, Gauteng, South Africa
Evelynne S Fulda
Massachusetts General Hospital, Boston, MA, USA
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INTRODUCTION OF SPEAKERS PART I
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
GEOGRAPHICAL DIFFERENCES IN FUNCTIONAL IMPAIRMENT OF PEOPLE WITH HIV   (ABSTRACT 34)
Kristine Erlandson
University of Colorado, Denver, CO, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
ANTICHOLINERGIC MEDICATIONS ASSOCIATED WITH FALLS AND FRAILTY IN PEOPLE WITH HIV   (ABSTRACT 35)
Jessica Doctor
Guy's and St Thomas' Hospital, London, United Kingdom
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INFLAMMATION AND KYNURENINE PATHWAY LINKED TO TYPE 2 DIABETES AND FAT FIBROSIS IN HIV   (ABSTRACT 36)
Diana L Alba
University of California San Francisco, San Francisco, CA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
GUT MICROBIOTA, PLASMA METABOLOMICS, AND ATHEROSCLEROSIS IN HIV INFECTION   (ABSTRACT 37)
Zheng Wang
Albert Einstein College of Medicine, Bronx, NY, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
Diana L Alba
University of California San Francisco, San Francisco, CA, USA
Jessica Doctor
Guy's and St Thomas' Hospital, London, United Kingdom
Kristine Erlandson
University of Colorado, Denver, CO, USA
Zheng Wang
Albert Einstein College of Medicine, Bronx, NY, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
MACROPHAGE ARTERIAL INFILTRATION RELATES TO PLAQUE TYPE AND IMMUNE ACTIVATION IN HIV   (ABSTRACT 38)
Mabel Toribio
Massachusetts General Hospital, Boston, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
TRENDS IN MYOCARDIAL INFARCTION RISK BY HIV STATUS IN TWO US HEALTHCARE SYSTEMS   (ABSTRACT 39)
Michael J Silverberg
Kaiser Permanente Northern California, Oakland, CA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
NONSMALL CELL LUNG CARCINOMA IN PLWH HARBORS IMMUNOREGULATORY TUMOR MICROENVIRONMENT   (ABSTRACT 40)
Syim Salahuddin
Yale School of Medicine, New Haven, CT, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
HPV GENOTYPING IN STUDY OF ADJUNCTIVE VACCINE FOR TREATMENT OF CERVICAL DYSPLASIA   (ABSTRACT 41)
Grant Ellsworth
Weill Cornell Medicine, New York, NY, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
ANGIOGENIC FACTORS IN RNA-SEQ OF SKIN AND GASTROINTESTINAL KAPOSI SARCOMA LESIONS   (ABSTRACT 42)
Joseph Ziegelbauer
National Cancer Institute, ,
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Judith S Currier
University of California Los Angeles, Los Angeles, CA, USA
Grant Ellsworth
Weill Cornell Medicine, New York, NY, USA
Syim Salahuddin
Yale School of Medicine, New Haven, CT, USA
Michael J Silverberg
Kaiser Permanente Northern California, Oakland, CA, USA
Mabel Toribio
Massachusetts General Hospital, Boston, USA
Joseph Ziegelbauer
National Cancer Institute, ,
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
INTRODUCTION OF SPEAKERS PART I
Landon Myer
University of Cape Town, Cape Town, South Africa
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
UNIVERSAL HEPATITIS C VIRUS SCREENING IN PREGNANCY: THE JUICE IS WORTH THE SQUEEZE   (ABSTRACT 27)
Catherine Anne Chappell
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
HBIG-FREE STRATEGY TO PREVENT HBV MOTHER-TO-CHILD TRANSMISSION: ANRS TA PROHM STUDY   (ABSTRACT 28)
Olivier Segeral
French National Agency for Research on AIDS, Phnom Penh, Cambodia
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
THE IMPACT OF COVID-19 ON ADVERSE BIRTH OUTCOMES IN BOTSWANA BY HIV STATUS   (ABSTRACT 29)
Maya Jackson-Gibson
Northwestern University, Chicago, IL, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
GROWTH OF INFANTS WITH PERINATAL EXPOSURE TO MATERNAL DTG VS EFV AND TDF VS TAF   (ABSTRACT 30)
Lynda Stranix-Chibanda
University of Zimbabwe, Harare, Zimbabwe
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Landon Myer
University of Cape Town, Cape Town, South Africa
Catherine Anne Chappell
University of Pittsburgh, Pittsburgh, PA, USA
Maya Jackson-Gibson
Northwestern University, Chicago, IL, USA
Olivier Segeral
French National Agency for Research on AIDS, Phnom Penh, Cambodia
Lynda Stranix-Chibanda
University of Zimbabwe, Harare, Zimbabwe
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
TWO-YEAR VIROLOGIC OUTCOMES OF VERY EARLY ART FOR INFANTS IN THE IMPAACT P1115 STUDY   (ABSTRACT 31)
Deborah Persaud
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
TREATMENT WITH BROADLY NEUTRALIZING ANTIBODIES IN CHILDREN WITH HIV IN BOTSWANA   (ABSTRACT 32)
Roger L Shapiro
Harvard TH Chan School of Public Health, Boston, MA, USA
from CROI 2022 on February 14, 2022 9:45 AM-11:45 AM
<< first | < prev next > | last >>
presentations: 1 to 50 of 3196
page: of 64 records per page: